Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $132.26 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CooperSurgical, Inc. | $38.43 | 3 | $0 (2022) |
| Hologic, LLC | $27.52 | 2 | $0 (2019) |
| AbbVie Inc. | $26.85 | 1 | $0 (2021) |
| PFIZER INC. | $23.52 | 2 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $15.94 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $15.94 | 1 | Bayer Healthcare Pharmaceuticals Inc. ($15.94) |
| 2022 | $26.40 | 2 | CooperSurgical, Inc. ($14.23) |
| 2021 | $50.56 | 3 | AbbVie Inc. ($26.85) |
| 2019 | $25.79 | 2 | Hologic, LLC ($13.95) |
| 2018 | $13.57 | 1 | Hologic, LLC ($13.57) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/24/2023 | Bayer Healthcare Pharmaceuticals Inc. | Mirena (Drug), Kyleena | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Womens Health | ||||||
| 10/25/2022 | PFIZER INC. | MYFEMBREE (Drug), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 03/15/2022 | CooperSurgical, Inc. | Paragard (Device) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Endocrinology | ||||||
| 10/01/2021 | PFIZER INC. | PREMARIN (Drug), MYFEMBREE | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: WOMENS HEALTH | ||||||
| 05/20/2021 | CooperSurgical, Inc. | Paragard (Device) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: Endocrinology | ||||||
| 05/18/2021 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $26.85 | General |
| 09/10/2019 | CooperSurgical, Inc. | Paragard (Device) | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: Endocrinology | ||||||
| 02/26/2019 | Hologic, LLC | Omniscope (Device), Novasure | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Surgical | ||||||
| 06/28/2018 | Hologic, LLC | Fluent (Device), SURGITRON | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Surgical | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 57 | 62 | $6,825 | $2,481 |
| 2022 | 3 | 73 | 88 | $9,455 | $4,288 |
| 2021 | 3 | 108 | 121 | $12,315 | $5,027 |
| 2020 | 2 | 59 | 76 | $8,500 | $3,249 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 37 | 37 | $3,700 | $1,376 | 37.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 25 | $3,125 | $1,105 | 35.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 39 | $4,875 | $2,386 | 49.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 33 | 33 | $3,300 | $1,255 | 38.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 16 | $1,280 | $645.98 | 50.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 71 | 71 | $7,100 | $2,712 | 38.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 23 | 27 | $3,375 | $1,789 | 53.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 14 | 23 | $1,840 | $526.20 | 28.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 19 | 36 | $4,500 | $1,688 | 37.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 40 | 40 | $4,000 | $1,561 | 39.0% |
About Dr. Beth Maxwell, M.D
Dr. Beth Maxwell, M.D is a Specialist healthcare provider based in Latrobe, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1689671422.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Beth Maxwell, M.D has received a total of $132.26 in payments from pharmaceutical and medical device companies, with $15.94 received in 2023. These payments were reported across 9 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($132.26).
As a Medicare-enrolled provider, Maxwell has provided services to 297 Medicare beneficiaries, totaling 347 services with total Medicare billing of $15,045. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Obstetrics & Gynecology
- Location Latrobe, PA
- Active Since 07/07/2005
- Last Updated 01/26/2017
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1689671422
Products in Payments
- Paragard (Device) $38.43
- Mirena (Drug) $15.94
- Omniscope (Device) $13.95
- Fluent (Device) $13.57
- MYFEMBREE (Drug) $12.17
- PREMARIN (Drug) $11.35
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.